TW375525B - Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives - Google Patents

Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives

Info

Publication number
TW375525B
TW375525B TW087100930A TW87100930A TW375525B TW 375525 B TW375525 B TW 375525B TW 087100930 A TW087100930 A TW 087100930A TW 87100930 A TW87100930 A TW 87100930A TW 375525 B TW375525 B TW 375525B
Authority
TW
Taiwan
Prior art keywords
morphine
inhibitors
ethyl
active components
containing active
Prior art date
Application number
TW087100930A
Other languages
Chinese (zh)
Inventor
Naoyuki Yoshida
Takashi Yoshikawa
Shiro Kato
Yoshimi Hirokawa
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Application granted granted Critical
Publication of TW375525B publication Critical patent/TW375525B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

This invention relates to inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives of the formula (1), (wherein Ar represents 5-bromo-2-methoxy-6-methylamino-3-pyridyl, or 5-chloro-2-methoxy-4-methylaminophenyl), or the physically acceptable acid additive salts thereof.
TW087100930A 1997-01-28 1998-01-23 Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives TW375525B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2957397A JPH10203987A (en) 1997-01-28 1997-01-28 Agent containing (r)-1-ethyl-4-methylhexahydro-1h-1,4-diazepine derivative as active component and effective for suppressing vomition induced by morphine-like agent

Publications (1)

Publication Number Publication Date
TW375525B true TW375525B (en) 1999-12-01

Family

ID=12279865

Family Applications (1)

Application Number Title Priority Date Filing Date
TW087100930A TW375525B (en) 1997-01-28 1998-01-23 Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives

Country Status (2)

Country Link
JP (1) JPH10203987A (en)
TW (1) TW375525B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03000145A (en) 2002-01-07 2003-07-15 Pfizer Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators.
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
MXPA06014486A (en) 2004-06-15 2007-03-01 Pfizer Benzimidazolone carboxylic acid derivatives.
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
CN102333763A (en) 2009-03-31 2012-01-25 善利亚新药工业股份有限公司 1, 5-benzene diazide derivs

Also Published As

Publication number Publication date
JPH10203987A (en) 1998-08-04

Similar Documents

Publication Publication Date Title
ES2182852T3 (en) PROLINAMIDE DERIVATIVES
IL114315A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same for inhibiting phosphodiesterase IV
EP1277754B8 (en) Imidazopyridine derivatives
IL143545A0 (en) Thrombin inhibitors
TW239126B (en)
WO2002098856A3 (en) Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
ES2150489T3 (en) 1-AMIDINOFENIL-PIRROLIDONAS, -PIPERIDINONAS, -AZETINONAS AS INHIBITORS OF THE AGGREGATION OF PLATELETS.
PL334915A1 (en) Pyrrolidine derivatives exhibiting phospholipase a2 inhibiting activity
EE200300403A (en) N-substituted Non-Aromatic Heterocyclic Compound, Pharmaceutical Composition Containing It, and Use of the Compound as a Pharmaceutical
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
DE60118225D1 (en) CHINOLIN AND CHINAZOLINE DERIVATIVES AND THEIR USE AS FARNESYL TRANSFERASE INHIBITORS
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
TR200102490T2 (en) Phenyl and pyridinyl derivatives
BG103485A (en) Ketobanzamides as calpain inhibitors
IL124944A (en) Quinolonecarboxylic acid derivatives or their salts and pharmaceutical compositions containing them
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
CA2244777A1 (en) 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
IL136359A (en) Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same
BG104447A (en) Biphenylamidine derivatives
AU2003223340A8 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
WO2002000638A3 (en) Substituted phthalides as anti-convulsive drugs
GR3021143T3 (en) Imidazole derivatives and pharmaceutical compositions containing the same.
TW375525B (en) Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives
PT1234818E (en) CALCIUM SALTS OF 1,5-BENZODIAZEPINE DERIVATIVES, PROCESS FOR PRODUCTION OF SALTS AND DRUGS THAT CONTAIN THEM
PL361850A1 (en) Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines